Li Y, Deng JJ, Jiang J. Relationship between body mass index and short-term postoperative prognosis in patients undergoing colorectal cancer surgery. World J Clin Cases 2023; 11(12): 2766-2779 [PMID: 37214581 DOI: 10.12998/wjcc.v11.i12.2766]
Corresponding Author of This Article
Jun Jiang, MD, Chief Doctor, Department of Thyroid Surgery, The Affiliated Hospital of Southwest Medical University, No. 25 Taiping Street, Luzhou 646000, Sichuan Province, China. jiangjun2023@yeah.net
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Meta-Analysis
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Apr 26, 2023; 11(12): 2766-2779 Published online Apr 26, 2023. doi: 10.12998/wjcc.v11.i12.2766
Relationship between body mass index and short-term postoperative prognosis in patients undergoing colorectal cancer surgery
Ying Li, Ji-Jun Deng, Jun Jiang
Ying Li, Jun Jiang, Department of Thyroid Surgery, the Affiliated Hospital of Southwest Medical University, Luzhou 646000, Sichuan Province, China
Ji-Jun Deng, Department of Ultrasound Imaging, Affiliated Hospital of Traditional Chinese Medicine of Southwest Medical University, Luzhou 646000, Sichuan Province, China
Author contributions: Li Y conceptualized and designed the study, and collected and compiled the data; Jiang J provided administrative support; Li Y provided the research materials and patients; Deng JJ and Jun Jiang analyzed and interpreted the data; and all authors wrote and approved the final version of the manuscript.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
PRISMA 2009 Checklist statement: We have read the PRISMA 2009 checklist and the manuscript has been prepared and revised based on the PRISMA 2009 checklist.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Jun Jiang, MD, Chief Doctor, Department of Thyroid Surgery, The Affiliated Hospital of Southwest Medical University, No. 25 Taiping Street, Luzhou 646000, Sichuan Province, China. jiangjun2023@yeah.net
Received: March 2, 2023 Peer-review started: March 2, 2023 First decision: March 14, 2023 Revised: March 18, 2023 Accepted: March 24, 2023 Article in press: March 24, 2023 Published online: April 26, 2023 Processing time: 54 Days and 15.4 Hours
Core Tip
Core Tip: Colorectal rectal cancer (CRC) is a common malignant tumor in gastroenterology, ranking the third in the global incidence rate of malignant tumors, second only to lung cancer and breast cancer, with a mortality rate of about 8% of all malignant tumors. Like other malignant tumors, the etiology of CRC is still unclear. It may occur in the colon or anywhere in the rectum, but it is most common in the rectum and sigmoid colon, and the rest are in the cecum, ascending colon, descending colon and transverse colon in turn. So far, the radical treatment of CRC is still surgical treatment. The definition of radical cancer resection is to remove tumors visible to the naked eye, including primary and drainage lymph nodes. Although lesions can be removed during surgery, complete removal is still not easy for patients with extensive local diseases. For patients with advanced CRC, the tumor size is relatively large, there are many vascular variations, the field of vision of laparotomy is poor, and the operation is difficult.
